BillionaireClubCollc
  • News
  • Notifications
  • Shop
  • Cart
  • Media
  • Advertise with Us
  • Profile
  • Groups
  • Games
  • My Story
  • Chat
  • Contact Us
home shop notifications more
Signin
  •  Profile
  •  Sign Out
Skip to content

Billionaire Club Co LLC

Believe It and You Will Achieve It

Primary Menu
  • Home
  • Politics
  • TSR
  • Anime
  • Michael Jordan vs.Lebron James
  • Crypto
  • Soccer
  • Dating
  • Airplanes
  • Forex
  • Tax
  • New Movies Coming Soon
  • Games
  • CRYPTO INSURANCE
  • Sport
  • MEMES
  • K-POP
  • AI
  • The Bahamas
  • Digital NoMad
  • Joke of the Day
  • RapVerse
  • Stocks
  • SPORTS BETTING
  • Glamour
  • Beauty
  • Travel
  • Celebrity Net Worth
  • TMZ
  • Lotto
  • COVD-19
  • Fitness
  • The Bible is REAL
  • OutDoor Activity
  • Lifestyle
  • Culture
  • Boxing
  • Food
  • LGBTQ
  • Poetry
  • Music
  • Misc
  • Open Source
  • NASA
  • Science
  • Natural & Holstict Med
  • Gardening
  • DYI
  • History
  • Art
  • Education
  • Pets
  • Aliens
  • Astrology
  • Farming and LiveStock
  • LAW
  • Fast & Furious
  • Fishing & Hunting
  • Health
  • Credit Repair
  • Grants
  • All things legal
  • Reality TV
  • Africa Today
  • China Today
  • "DUMB SHIT.."
  • Stocks

Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal

Photo by Scott Olson / Getty Images

Key TakeawaysEli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly worth $5 billion. The company's stock was upgraded by Deutsche Bank analysts following its quarterly results last week.Lilly shares jumped early in the day but closed in the red.
Eli Lilly (LLY) shares finished Monday lower after a back-and-forth session in which an analyst upgrade sent them higher before news of $5 billion in bond sales pulled them into the red.Deutsche Bank analysts called the drugmaker a “high growth unicorn” and upgraded its shares to a buy rating. The bump was based in part on sales of the weight-loss drug Mounjaro, which more than tripled to $3.09 billion when the company reported earnings last weekThe firm upgraded its price target to $1,025 from $725, a nearly 15% premium to Lilly’s Friday closing price. Shares rose above $904 Monday morning. Bonds Help Fund Morphic AcquisitionThe stock gave back its early gains after Bloomberg in a report said the company would sell $5 billion in bonds to help pay for its $3.2 billion acquisition of Morphic (MORF). Lilly in a regulatory filing confirmed the sale but offered fewer details.The deal, announced last month, adds Morphic’s flagship developmental drug for inflammatory bowel disease to Lilly’s portfolio. The company is also developing molecules intended to treat autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases, and cancer.Lilly will sell bonds in five chunks, including a 40-year note with a 1% higher yield than a U.S. Treasury note, according to the report. Corporate bonds are typically seen as riskier than U.S. government bonds, so they usually have higher interest rates to compensate.An Eli Lilly spokesperson declined to comment. Shares of the company closed Monday's session down less than 1%, Read the original article on Investopedia.

Welcome to Billionaire Club Co LLC, your gateway to a brand-new social media experience! Sign up today and dive into over 10,000 fresh daily articles and videos curated just for your enjoyment. Enjoy the ad free experience, unlimited content interactions, and get that coveted blue check verification—all for just $1 a month!

Source link

Share
What's your thought on the article, write a comment
0 Comments
×

Sign In to perform this Activity

Sign in
×

Account Frozen

Your account is frozen. You can still view content but cannot interact with it.

Please go to your settings to update your account status.

Open Profile Settings

Ads

  • Billionaire128 Liquid Gold Flag

    $ 25.00
  • Premium Billionaire128 Cuffed Beanie

    $ 19.50
  • Billionaire128 Liquid Gold Yoga Shorts

    $ 30.50
  • News Social

    • Facebook
    • Twitter
    • Facebook
    • Twitter
    Copyright © 2024 Billionaire Club Co LLC. All rights reserved